The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
TIDMNCYT
RNS Number : 1286J
Novacyt S.A.
08 April 2020
Novacyt S.A.
("Novacyt" or the "Company")
COVID-19 test eligible for WHO Emergency Use Listing
Paris, France and Camberley, UK - 8 April 2020 - Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces that its test for COVID-19 (Z-Path COVID-19-CE IVD) has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process. The test will be eligible for procurement for one year, unless circumstances dictate otherwise. The test has been developed by Novacyt's molecular diagnostics division, Primerdesign, based in Southampton, UK.
The EUL is a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency. It will assist interested UN procurement agencies and Member States in determining the acceptability of using specific products, based on an essential set of available quality, safety, and efficacy and performance data. The procedure is a key tool for companies wishing to submit their products for use during health emergencies.
Graham Mullis, Chief Executive Officer of Novacyt, commented:
"The Emergency Use Listing by the WHO importantly provides further validation of our COVID-19 test and gives government agencies around the world further confidence in the effectiveness of our test."
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
- End -
Having re-read Tuesday's RNS did anyone notice this.....?
Graham Mullis, Chief Executive Officer of Novacyt, commented: "We continue to report unprecedented demand for our COVID-19 test as the rate of growth in orders increases each week and continues to exceed our expectations."
"The RATE OF GROWTH in orders increases". That doesn't just mean that orders are increasing. It means that each increase in orders is greater than the last increase. I believe the term is 'Exponential'. GLA